Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: Clinical benefit outweighs disadvantage

British Journal of Biomedical Science

Volumn 56, Issue 1, 1999, Pages 49-55

  Shields, Janette A ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

Erythroblastosis, fetal; Prenatal diagnosis

Indexed keywords

ANTIGEN; BILIRUBIN; DNA; HEMOGLOBIN F; IMMUNOGLOBULIN G; MATERNAL ANTIBODY; RHESUS D ANTIBODY;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; BLOOD GROUP TYPING; DNA DETERMINATION; ELECTRIC POTENTIAL; ERYTHROCYTE; FETUS; FETUS BLOOD; FIRST TRIMESTER PREGNANCY; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMALLY INVASIVE SURGERY; NEWBORN HEMOLYTIC DISEASE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROPHYLAXIS; SENSITIZATION;

BLOOD GROUPING AND CROSSMATCHING; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM;

EID: 0032928723     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mollison PL, Engelfriet CP, Contreras M. Haemolytic disease of the newborn. In: Blood transfusion in clinical medicine, 8th Edition. Oxford: Blackwell Scientific Publications, 1987: 637-87.
2. Van der Meulen JA, McNabb TC, Haeffner-Cavaillon N. The Fc receptor on human placental plasma membrane. G J Immunol 1980; 124:500-7.
3. Tannirandorn Y, Rodeck CH. New approaches in the treatment of haemolytic disease of the foetus. In: Contreras M, ed. Blood transfusion: the impact of new technologies. London: Baillière, 1990.
4. Urbaniak SJ. Rh (D) haemolytic disease of the newborn: the changing scene. BMJ 1985; 291:4-6.
5. Tovey LAD. Haemolytic disease of the newborn - the changing scene. Br J Obstet Gynaecol 1986; 93:960-6.
6. Clarke CA, Whitfield AGW, Mollison PL. Death from Rh haemolytic disease in England and Wales in 1984 and 1985. BMJ 1987; 294:1001.
7. Bowell PJ, Waincoat JS, Peto TEA et al Maternal anti D concentrations and outcome in Rhesus haemolytic disease of the newborn. BMJ 1982; 285:327-9.
8. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitisation. Am J Obstet Gynecol 1961; 82:1359-70.
9. Nicolaides KH, Rodeck CH, Millar DS et al. Fetal haematology in Rhesus isoimmunization. BMJ 1985; 220:661-3.
10. McKenzie IZ, Bowell PJ, Castle PM et al; Serial fetal blood sampling for the management of pregnancies complicated by severe Rhesus (D) isoimmunization. Br J Obstet Gynaecol 1988; 95:753-8.
11. Whitfield CR. A three year assessment of an action line method of timing intervention in Rhesus isoimmunization. Am J Obstet Gynecol 1970; 108:1239-44.
12. Rodeck CH, Campbell S. Sampling pure fetal blood by foetoscopy in second trimester of pregnancy. BMJ 1978; 42:728-30.
13. Daffos F, Forestier F, Capella-Pavlovsky M. Fetal blood sampling during the third trimester of pregnancy. Br J Obstet Gynaecol 1984; 91:118-21.
14. Rodeck CH, Letsky E. How the management of erythroblastosis foetalis has changed. Br J Obstet Gynaecol 1989; 96:759-63.
15. Vaughan JI, Warwick R, Letsky E et al. Erythropoietic suppression in foetal anaemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171(1):247-52.
16. Kanahi HH, Gravenshorst JB, Gemke RJ. Foetal blood group determination in first trimester pregnancy for the management of severe immunization. Am J Obstet Gynecol 1987; 156:120-3.
17. Warren RC, Butler J, Morsman JM et al. Does chorionic villus sampling cause foeto-maternal haemorrhage? Lancet 1985; i:691.
18. Le Van Kim C, Mouro I, Cherif-Zahar B et al. Molecular cloning and primary structure of the human blood group Rh D polypeptide. Proc Natl Acad Sci USA 1992; 89:10925-9.
19. Colin Y, Cherif-Zahar B, Le Van Kim C et al. Genetic basis of the Rh D positive and Rh D negative blood group polymorphisms as determined by Southern analysis. Blood 1991; 78:2747-52.
20. Bennett PR, Le Van Kim C, Colin Y et al. Prenatal determination of foetal Rh D type by DNA amplification. N Engl J Med 1993; 329:607-10.
21. Simsek S, Blesker PMM, Von Dem Borne AEGKr. Prenatal determination of foetal Rh D type. N Engl J Med 1994; 330: 795-6.
22. Avent ND, Martin PG, Carritt B. Improved Rh D genotyping assay for prenatal determination of fetal Rh D status: the exon 10/intron 4 PCR multiplex assay. Presentation: BBTS XIII Annual Scientific Meeting, September 1995. Transfus Med 1995; 5(Suppl):20.
23. Lo Y-MD, Bowell PJ, Sellinger M et al. Prenatal determination of foetal Rh D status by analysis of peripheral blood of Rhesus negative mothers. Lancet 1993; 341:1147-8.
24. Lo Y-MD, Noakes L, Bowell PJ el al. Detection of foetal Rh D sequence from peripheral blood of sensitized Rh D negative pregnant women. Br J Haematol 1994; 87:658-60.
25. Simpson JL, Elias S. Isolating foetal cells from maternal blood: advances in prenatal diagnosis through molecular technology. JAMA 1993; 270:2357-61.
26. Hamada H, Arinami T, Kubo T et al. Foetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age. Hum Genet 1993; 91:427-32.
27. Lo Y-MD, Patel P, Sampietro M et al. Detection of single copy foetal DNA sequence from maternal blood. Lancet 1990; 335:1463-4.
28. Le Van Kim C, Mouro I, Broussard Y et al. PCR based determination of Rh c and Rh E status of foetuses at risk of Rh c and Rh E haemolytic disease. Br J Haematol 1994; 88:193-5.
29. Adinolfi M, Sherlock J, Kemp T. Prenatal diagnosis of foetal Rh D DNA sequences in transcervical samples. Lancet 1995; 345:318-19.
30. Bennett PR, Overton TG, Lighten AD et al. Rh D typing. Lancet 1995; 345:661-2.
31. Berlin G, Selbing A, Ryden G. Rhesus haemolytic disease treated with high dose. immunoglobulin. Lancet 1985; i:1153.